why choose us

First received: September 11, 2023

Clinical Trial: A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study to Investigate the Effect of LY3437943 on the Pharmacokinetics of the Combined Oral Contraceptive Ethinyl Estradiol and Drospirenone in Female Participants

Brief Summary: The main purpose of this study is to determine the effect of LY3437943 when administered subcutaneously on the levels of combined oral contraceptive (COC) ethinyl estradiol and drospirenone in the blood stream in postmenopausal female participants who are overweight or obese.The safety and tolerability of LY3437943 when administered with COC will also be evaluated.This study will last up to approximately 29 weeks for each participant.

Read more